论文部分内容阅读
英国细胞周期公司(UK cell cycle company)Prolifix最近鉴别到一种新的蛋白质STRAP，可能会成为避免健康细胞受到伤害的癌症化疗的有效靶点。该蛋白质作为p300和JMY两种蛋白质的连结部位，与一系列导致癌细胞凋亡的级联反应相关。据Prolifix说，阻滞STRAP可选择性作用于健康组
Prolifix, a UK cell cycle company, recently identified a new protein, STRAP, that could be a valid target for cancer chemotherapy to prevent healthy cells from being harmed. This protein, as the junction between p300 and JMY, is associated with a series of cascades that cause apoptosis in cancer cells. According to Prolifix, blockade of STRAP can act selectively in healthy subjects